Hepatoblastoma — Trials

Hepatoblastoma — Trials · CancerIndex

Clinical trials

Registered studies

61 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 11
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00980460	Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer	completed	Phase 3	236	National Cancer Institute (NCI)NIH	6	Jun 30, 2026	clinicaltrials
NCT00003994	Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer	completed	Phase 3	277	Children's Oncology GroupNETWORK	1	Jun 14, 2013	clinicaltrials